Glutamatergic systems in Alzheimer's disease
- 1 September 2003
- journal article
- conference paper
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 18 (S1) , S15-S21
- https://doi.org/10.1002/gps.934
Abstract
Glutamate is the major transmitter of the brain and is involved in all aspects of cognitive function since it is the transmitter of cortical and hippocampal pyramidal neurones. Furthermore, glutamate and glutamate receptors are involved in long‐term potentiation, a process believed to underlie learning and memory. Histological studies indicate loss of pyramidal neurones and their synapses in Alzheimer's disease (AD), this together with biochemical evidence suggests presynaptic (and postsynaptic) glutamatergic hypoactivity. This represents a ‘double blow’ as the activity of glutamatergic neurones is heavily influenced by the cholinergic system, which is also dysfunctional in AD. The clinical relevance of these changes is emphasised because glutamatergic and cholinergic dysfunction are strong correlates of cognitive decline in AD. The mechanism by which glutamatergic (and cholinergic) cells die is likely to be a combination of necrosis and apoptosis caused by a range of factors which include tangle formation and the effects of too much and too little glutamatergic neurotransmission. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 65 references indexed in Scilit:
- Remembrance of Arguments Past: How Well Is the Glutamate Receptor Hypothesis of LTP Holding Up after 20 Years?Neurobiology of Learning and Memory, 2001
- Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer's diseaseJournal of Neuroscience Research, 1999
- Amyloid β-protein toxicity and oxidative stress in Alzheimer's diseaseCell and tissue research, 1997
- Oxidative damage in Alzheimer'sNature, 1996
- Nicotinic and muscarinic receptor-evoked depolarizations recorded from a novel cortical brain slice preparationNeuropharmacology, 1995
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Spermidine enhancement of [3H]MK-801 binding to the NMDA receptor complex in human cortical membranesEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Presynaptic and postsynaptic glutamatergic function in Alzheimer's diseaseNeuroscience Letters, 1988
- Glutamate dysfunction in Alzheimer's disease: an hypothesisTrends in Neurosciences, 1987
- Na+‐Dependent “Binding” of D‐Aspartate in Brain Membranes Is Largely Due to Uptake into Membrane‐Bounded SacculesJournal of Neurochemistry, 1986